2006
DOI: 10.1177/026119290603400307
|View full text |Cite
|
Sign up to set email alerts
|

The Assessment of Repeated Dose Toxicity In Vitro: A Proposed Approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(23 citation statements)
references
References 119 publications
(99 reference statements)
0
21
0
1
Order By: Relevance
“…Cell lines have often lost the specific functional properties of their in vivo equivalents and do not always provide full and stable phenotypes (Prieto et al 2006). There are a number of differences between in vitro and in vivo studies (e.g., different species, exposure doses and times).…”
Section: Discussionmentioning
confidence: 99%
“…Cell lines have often lost the specific functional properties of their in vivo equivalents and do not always provide full and stable phenotypes (Prieto et al 2006). There are a number of differences between in vitro and in vivo studies (e.g., different species, exposure doses and times).…”
Section: Discussionmentioning
confidence: 99%
“…Usually risk assessment in humans is based on data extrapolated from animals. As Prieto et al (2006) pointed out, this approach is not based on scientific evidence, and additional data on the mechanism of animal and human toxic effects are needed. With the ban of animal testing in cosmetic ingredients, in vitro techniques and IVIVE methods are required.…”
Section: Discussionmentioning
confidence: 99%
“…However, as Adler et al (2011) reported, repeated dose toxicity is difficult to predict, especially based on in vitro data alone, since it results from longterm repeated exposure to a chemical leading to the deterioration of cells or organs as a result of their interplay. As discussed in Prieto et al (2006), the toxicity of the most affected isolated organ after repeated exposure can be assessed based on in vitro data provided relevant in vitro approaches are developed and kinetics is accounted for through modelling. Since the liver is the organ most frequently affected by chronic toxicity following repeated oral exposure to xenobiotics (Bitsch et al, 2006), the priority in the development of alternatives to repeated dose toxicity testing have focused on hepatotoxicity.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, current efforts are geared toward replacing animal chronic toxicity models with technologically driven human cell-based models. These nonanimal alternative models for chronic toxicity testing include human and animal perfused organs; organ tissue slices; isolated, suspended cells; primary cultured cells; cultured cell lines; genetically engineered cell lines; reaggregating cell cultures; three-dimensional cell cultures and co-cultures; and (quantitative) structure activity relationship [(Q)SAR] computational systems [84,85].…”
Section: Nonanimal Alternative Methodsmentioning
confidence: 99%
“…Like the liver, perfused whole kidney and kidney slices have been used to test drugs and chemicals for short periods of time [83]. Kidney tubule cell cultures and cell lines have been developed, and some can be maintained for extended periods [85]. Likewise, cells from other human organs such as lung and brain, as well as blood and immune cells have been cultured for toxicity testing.…”
Section: Nonanimal Alternative Methodsmentioning
confidence: 99%